CRDF logo

Cardiff Oncology (CRDF) Working Capital

Annual Working Capital

$66.97 M
-$36.50 M-35.28%

31 December 2023

CRDF Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$46.81 M
-$2.92 M-5.87%

30 September 2024

CRDF Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRDF Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-35.3%-37.5%
3 y3 years-47.4%-64.7%
5 y5 years+580.5%+706.2%

CRDF Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-52.0%at low-66.5%at low
5 y5 years-52.0%+919.0%-66.5%+766.5%
alltimeall time-52.0%+2235.0%-66.5%+5759.9%

Cardiff Oncology Working Capital History

DateAnnualQuarterly
Sept 2024
-
$46.81 M(-5.9%)
June 2024
-
$49.72 M(-14.5%)
Mar 2024
-
$58.15 M(-13.2%)
Dec 2023
$66.97 M(-35.3%)
$66.97 M(-10.6%)
Sept 2023
-
$74.89 M(-10.4%)
June 2023
-
$83.61 M(-10.7%)
Mar 2023
-
$93.61 M(-9.5%)
Dec 2022
$103.48 M(-25.9%)
$103.48 M(-7.2%)
Sept 2022
-
$111.51 M(-6.2%)
June 2022
-
$118.93 M(-7.9%)
Mar 2022
-
$129.14 M(-7.5%)
Dec 2021
$139.57 M(+9.7%)
$139.57 M(+5.2%)
Sept 2021
-
$132.73 M(-4.0%)
June 2021
-
$138.29 M(+11.4%)
Mar 2021
-
$124.09 M(-2.5%)
Dec 2020
$127.24 M(+1836.0%)
$127.24 M(+288.6%)
Sept 2020
-
$32.75 M(+37.3%)
June 2020
-
$23.86 M(+341.7%)
Mar 2020
-
$5.40 M(-17.8%)
Dec 2019
$6.57 M(-33.2%)
$6.57 M(+13.2%)
Sept 2019
-
$5.81 M(-28.6%)
June 2019
-
$8.13 M(-10.2%)
Mar 2019
-
$9.05 M(-8.0%)
Dec 2018
$9.84 M
$9.84 M(-26.4%)
Sept 2018
-
$13.38 M(-18.6%)
June 2018
-
$16.43 M(+312.1%)
DateAnnualQuarterly
Mar 2018
-
$3.99 M(-27.8%)
Dec 2017
$5.52 M(-82.3%)
$5.52 M(+59.2%)
Sept 2017
-
$3.47 M(+190.8%)
June 2017
-
$1.19 M(-94.3%)
Mar 2017
-
$20.77 M(-33.3%)
Dec 2016
$31.15 M(-48.2%)
$31.15 M(-24.8%)
Sept 2016
-
$41.41 M(+1.7%)
June 2016
-
$40.73 M(-19.8%)
Mar 2016
-
$50.77 M(-15.6%)
Dec 2015
$60.18 M(+159.0%)
$60.18 M(-11.3%)
Sept 2015
-
$67.85 M(+83.6%)
June 2015
-
$36.95 M(-5.7%)
Mar 2015
-
$39.17 M(+68.6%)
Dec 2014
$23.23 M(-3.4%)
$23.23 M(-18.3%)
Sept 2014
-
$28.45 M(-13.9%)
June 2014
-
$33.05 M(+55.7%)
Mar 2014
-
$21.23 M(-11.8%)
Dec 2013
$24.06 M(+133.2%)
$24.06 M(-9.7%)
Sept 2013
-
$26.64 M(+277.2%)
June 2013
-
$7.06 M(-13.6%)
Mar 2013
-
$8.17 M(-20.8%)
Dec 2012
$10.32 M(-1855.6%)
$10.32 M(+42.5%)
Sept 2012
-
$7.24 M(-11.7%)
June 2012
-
$8.20 M(-1092.1%)
Mar 2012
-
-$827.00 K(+40.7%)
Dec 2011
-$587.70 K(-81.3%)
-$587.70 K
Dec 2010
-$3.14 M
-

FAQ

  • What is Cardiff Oncology annual working capital?
  • What is the all time high annual working capital for Cardiff Oncology?
  • What is Cardiff Oncology annual working capital year-on-year change?
  • What is Cardiff Oncology quarterly working capital?
  • What is the all time high quarterly working capital for Cardiff Oncology?
  • What is Cardiff Oncology quarterly working capital year-on-year change?

What is Cardiff Oncology annual working capital?

The current annual working capital of CRDF is $66.97 M

What is the all time high annual working capital for Cardiff Oncology?

Cardiff Oncology all-time high annual working capital is $139.57 M

What is Cardiff Oncology annual working capital year-on-year change?

Over the past year, CRDF annual working capital has changed by -$36.50 M (-35.28%)

What is Cardiff Oncology quarterly working capital?

The current quarterly working capital of CRDF is $46.81 M

What is the all time high quarterly working capital for Cardiff Oncology?

Cardiff Oncology all-time high quarterly working capital is $139.57 M

What is Cardiff Oncology quarterly working capital year-on-year change?

Over the past year, CRDF quarterly working capital has changed by -$28.08 M (-37.50%)